ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļICLR
āļāļ·āđāļāļāļĢāļīāļĐāļąāļICON PLC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 15, 1998
āļāļĩāļāļĩāđāļDr. Stephen (Steve) Cutler, Ph.D.
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ41900
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 15
āļāļĩāđāļāļĒāļđāđSouth County Business Park
āđāļĄāļ·āļāļDUBLIN
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ Global Select Consolidated
āļāļĢāļ°āđāļāļĻIreland
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ- -
āđāļāļĢāļĻāļąāļāļāđ35312912000
āđāļ§āđāļāđāļāļāđhttps://www.iconplc.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļICLR
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 15, 1998
āļāļĩāļāļĩāđāļDr. Stephen (Steve) Cutler, Ph.D.
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Ms. Julie O'Neill
Independent Director
Mr. Eugene Mccague
Independent Director
Dr. John Climax
Independent Director
Mr. Nigel Clerkin
Chief Financial Officer
Mr. Barry Edward Balfe
Chief Executive Officer, Chief Operating Officer
Chief Executive Officer, Chief Operating Officer
Ms. Anne C. Whitaker
Independent Director
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Non-Executive Director
Mr. Ronan Murphy
Lead Independent Director
Lead Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Ms. Julie O'Neill
Independent Director
Mr. Eugene Mccague
Independent Director
Dr. John Climax
Independent Director
Mr. Nigel Clerkin
Chief Financial Officer
Polen Capital International Growth ETF
Motley Fool Global Opportunities ETF
Invesco Bloomberg Pricing Power ETF
Running Oak Efficient Growth ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares MSCI Ireland ETF
āļŠāļąāļāļŠāđāļ§āļ4.59%
VanEck Biotech ETF
āļŠāļąāļāļŠāđāļ§āļ3.38%
Harbor Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ3.14%
Polen Capital International Growth ETF
āļŠāļąāļāļŠāđāļ§āļ3.14%
Motley Fool Global Opportunities ETF
āļŠāļąāļāļŠāđāļ§āļ2.9%
Invesco Bloomberg Pricing Power ETF
āļŠāļąāļāļŠāđāļ§āļ1.93%
Running Oak Efficient Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.83%
FPA Global Equity ETF
āļŠāļąāļāļŠāđāļ§āļ1.8%
Brandes US Value ETF
āļŠāļąāļāļŠāđāļ§āļ1.78%
Tema Durable Quality ETF
āļŠāļąāļāļŠāđāļ§āļ1.73%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ